2D10.1ICD-11 MMS 2026-01
Papillary carcinoma of thyroid gland
Description
A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland. Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries. Diagnostic procedures include: thyroid ultrasound, and fine needle biopsy. Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei. The nuclei also display clearing or have a ground glass appearance.
Coding note from above levels
For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.
Index terms
- Papillary carcinoma of thyroid gland
- papillary carcinoma, diffuse sclerosing, thyroid gland
- papillary thyroid cancer
Exclusions from above levels
- http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
- http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
- http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues
Sibling codes
2D10.0– Follicular carcinoma of thyroid gland2D10.2– Poorly differentiated carcinoma of thyroid gland2D10.3– Undifferentiated carcinoma of thyroid gland2D10.4– Medullary carcinoma of thyroid gland2D10.Y– Other specified malignant neoplasms of thyroid gland2D10.Z– Malignant neoplasms of thyroid gland, unspecified
Foundation entity
Papillary carcinoma of thyroid gland – http://id.who.int/icd/entity/929788705
Allowed postcoordination axes
Part of: 2D10: Malignant neoplasms of thyroid gland › 02: Neoplasms